The Future of Retinal Imaging exclusively at Snead Eye Group
- Visualize Vessels of the Retina and Choroid Non-Invasively
- Analyze Structure and Function with a Single Imaging Platform
- Your doctor can visualize their approach by Imaging As Often As Needed
The Transformative Power of OCT Angiography
Fast, Non-Invasive Imaging
Doctors can quickly visualize their patient’s microvasculature with a non-invasive, dye-free technique that can be accomplished by a trained technician in a matter of seconds. With AngioVue, patients can be imaged as often as needed to closely follow disease progression and treatment response. Unlike traditional invasive angiography approaches, there is no need for advance procedure scheduling because OCTA information is available as you perform the OCT scan.
3D Visualization of Retinal Vessels
AngioVue lets your doctor see the retinal vessels in a whole new way. Three-dimensional images are separated into individual layers of retinal vasculature to show your doctor an unprecedented level of detail and isolate areas of interest.
Optovue is the first company to develop and commercialize the pioneering OCTA technology. Utilizing light rays to form detailed three-dimensional images of the retina, physicians are able to quickly visualize the blood vessels. In less than three seconds, the AngioVue System acquires a single image that complements the current angiography imaging standard, fluorescein angiography (FA), but with a number of advantages. Unlike FA, the AngioVue System does not require the use of dye injections, which can often obscure the target anatomy and can lead to side effects and other complications associated with dye-based, invasive procedures.